日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell and spatial profiling reveal cDC2A-CXCL13(+)CD8(+) T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus

单细胞和空间分析揭示了皮肤和黏膜扁平苔藓中 cDC2A-CXCL13(+)CD8(+) T 上皮细胞通过 TNFRSF9 进行串扰和细胞毒性

Jiang, Rundong; Bogle, Rachael; Xing, Xianying; Kirma, Joseph; Fox, Jennifer; Harms, Paul W; Do, Tran; Billi, Allison C; Kahlenberg, J Michelle; Modlin, Robert L; Teles, Rosane; West, Julie; Mangold, Aaron; Zhang, Haihan; Schneider, Martin A; Bruno, Sandro; Roediger, Ben; Martiny-Baron, Georg; Tsoi, Lam C; Hacini-Rachinel, Feriel; Röhn, Till A; Gudjonsson, Johann E

Machine learning and network pharmacology identify keloid biomarkers (AMPH, TNFRSF9) and therapeutic targets (IL6, HAS2) for aloe-derived quercetin

机器学习和网络药理学鉴定出芦荟来源的槲皮素的瘢痕疙瘩生物标志物(AMPH、TNFRSF9)和治疗靶点(IL6、HAS2)

Jia, Congli; Yang, Fu; Li, Yingchun

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin's lymphoma

ADG106在晚期实体瘤和非霍奇金淋巴瘤患者中的临床前特征和I期结果

Yuxiang Ma ,Fan Luo ,Yang Zhang ,Qianwen Liu ,Jinhui Xue ,Yan Huang ,Yuanyuan Zhao ,Yunpeng Yang ,Wenfeng Fang ,Ting Zhou ,Gang Chen ,Jiaxin Cao ,Qun Chen ,Xiaohong She ,Peter Luo ,Guizhong Liu ,Li Zhang ,Hongyun Zhao

Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells

半乳糖神经酰胺上调 BCL2 基因的表达,下调 TNFRSF1B 和 TNFRSF9 基因的表达,在乳腺癌细胞中发挥抗凋亡分子的作用。

Suchanski, Jaroslaw; Reza, Safoura; Urbaniak, Anna; Woldanska, Weronika; Kocbach, Bartlomiej; Ugorski, Maciej

Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion

CD47在泛癌中的预后和免疫学作用分析:与TNFRSF9相互作用诱导CD8+T细胞耗竭

Liang, Hongxin; Zheng, Yong; Huang, Zekai; Dai, Jinchi; Yao, Lintong; Xie, Daipeng; Chen, Duo; Qiu, Hongrui; Wang, Huili; Li, Hao; Leng, Jinhang; Tang, Ziming; Zhang, Dongkun; Zhou, Haiyu

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism

短期培养肿瘤碎片,研究基于 CD137 (4-1BB) 激动剂的免疫疗法组合

Iñaki Eguren-Santamaría, Inmaculada Rodríguez, Claudia Herrero-Martin, Eva Fernández de Piérola, Arantza Azpilikueta, Sandra Sánchez-Gregorio, Elixabet Bolaños, Gabriel Gomis, Paula Molero-Glez, Enrique Chacón, José Ángel Mínguez, Santiago Chiva, Fernando Diez-Caballero, Carlos de Andrea, Álvaro Tei

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys

单次注射拉沙疫苗可对雄性食蟹猴产生快速保护作用

Mathieu Mateo, Stéphanie Reynard, Natalia Pietrosemoli, Emeline Perthame, Alexandra Journeaux, Kodie Noy, Clara Germain, Xavier Carnec, Caroline Picard, Virginie Borges-Cardoso, Jimmy Hortion, Hélène Lopez-Maestre, Pierrick Regnard, Lyne Fellmann, Audrey Vallve, Stéphane Barron, Ophélie Jourjon, Ori

Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites

抗 4-1BB 免疫疗法可增强放射治疗的全身免疫作用,从而诱导 B 细胞和 T 细胞依赖性抗肿瘤免疫激活并改善未受照射部位的肿瘤控制

Alexandra L Martin #, Chase Powell #, Mate Z Nagy, Patrick Innamarato, John Powers, Derek Nichols, Carmen M Anadon, Ricardo A Chaurio, Sungjune Kim, Min-Hsuan Wang, Bing Gong, Xianzhe Wang, Thomas J Scheutz, Scott J Antonia, Jose R Conejo-Garcia, Bradford A Perez

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

使用编码包含 IL-12、CD137 激动剂和 TGF-β 拮抗剂的嵌合蛋白构建体的 mRNA 进行肿瘤内免疫治疗

Assunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, Claudia Augusta Di Trani, Irene Olivera, Gabriel Gomis, Javier Glez-Vaz, Beatrice Pinci, Saray Garasa, Sandra Sánchez-Gregorio, Arantza Azpilikueta, Iñaki Eguren-Santamaria, Karmele Valencia, Belén Palencia, Maite Alvarez, Maria C Ochoa, Álvaro Tei

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease

一名患有严重 EBV 相关淋巴增生性疾病的患者因两种新的双等位基因 TNFRSF9 突变而出现 CD137 缺陷

Kefeng Shen, Jiachen Wang, Kuangguo Zhou, Wei Mu, Meilan Zhang, Xinyue Deng, Haodong Cai, Wei Zhang, Wei Huang, Min Xiao